Our health technology assessment institution is not into unconditional surrenders. It habitually buys time to consolidate its position with the goal of revisiting the issue. On the issue of multiple sclerosis medicines, this is what victory looks like in a single-payer system. …
It doesn't always feel like it, but make no mistake, this is what winning looks like
July 17, 2026 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
Most Australians want PBS medicine prices frozen or cut, poll finds
October 30, 2026 - - Latest News -
Canberra program shows young women where a future in health could take them
October 30, 2026 - - Latest News -
If only these patients needed a Spoodle, rather than a medicine
October 30, 2026 - - Latest News -
A hearing that provided more evidence of the need for meaningful change
October 29, 2026 - - Latest News -
Biotech sector warns R&D tax changes could drive clinical trials offshore
October 28, 2026 - - Latest News -
Rebates and net spend are the major PBS story of the past decade
October 28, 2026 - - Latest News -
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News